Special buckwheat: an extract with in vitro studies, with low glycemic impact
BuckNat® is obtained from buckwheat (Fagopyrum esculentum), a gluten-free pseudocereal, rich in nutrients and tested with in in vitro studies for its low glycemic index. BuckNat® is produced with the exclusive DEFS® technological system which does not use any chemical solvents.

COMPOSITION

BuckNat® is made from buckwheat, a low-calorie pseudocereal, rich in flavonoids, fatty acids, polysaccharides, amino acids, dietary fiber, resistant starch, B vitamins and minerals. Buckwheat proteins have a unique amino acid composition with beneficial cholesterol-lowering and antihypertensive properties.

PROPERTY

Low glycemic index
Gluten-free and suitable for coeliacs
Lactose-free and suitable for those with intolerances
Complete amino acid profile
Source of fiber
Rich in B vitamins and flavonoids
Antioxidant
Allergen-free

ACTIVITIES

Hypoglycemic
Hypocholesterolemic
Anti-inflammatory
Antioxidant and Free Radical Scavenger

USE

BuckNat® can be used as an ingredient and in combination with other extracts to formulate a nutraceutical or food product with a low glycemic index and suitable for coeliacs. Suitable for the formulation of food supplements, but also hot and cold drinks, energy drinks, snacks, baked goods.

BuckNat® is indicated for:

people with diabetes or with insulin resistance due to its low glycemic index
people with celiac disease because it is gluten-free
people with food intolerances
vegetarians and vegans because it is an excellent source of vegetable proteins
sportsmen and athletes who are keen to improve their sporting performance
those who want to implement a healthier and more balanced lifestyle

TESTS AND SCIENTIFIC EVIDENCE

The quality of BuckNat® has been confirmed by in vitro studies conducted by prestigious Italian universities: BuckNat® has a lower glycemic index than maltodextrin (GI 40 instead of 95) and after gastroduodenal digestion it caused the release of 18% less glucose compared to maltodextrin itself. The results of several studies conducted on BuckNat® show a significant reduction in insulin secretion of 77.8% compared to maltodextrin. Thanks to the NatIng DEFS® technological system, BuckNat® preserves essential macro / micro and trace elements typical of buckwheat.

Like AmaChol®, BuckNat® can modulate the intestinal absorption of cholesterol with respect to maltodextrin, usually used as a carrier in food supplements.
Thanks to the low glycemic index and high fiber content, AmaChol® and BuckNat® represent a valid option for the formulation of nutraceuticals and functional products useful as adjuvants in a nutritional plan aimed at improving metabolic values and general health conditions.